When Alexander Ginzburg injected himself with the vaccine he developed, he hadn't even begun testing the substance on monkeys. That was four months ago, and Ginzburg, a microbiologist and director of the state-owned Gamaleya Institute in Moscow, says he is still feeling just fine. One hundred institute employees also agreed to be vaccinated. And all are still healthy.Ginzburg is working on what is called a vector vaccine, which involves introducing genetic material from the SARS-CoV-2 virus into a harmless carrier virus in order to trigger the human immune system to produce antibodies. The...…When Alexander Ginzburg injected himself with the vaccine he developed, he hadn't even begun testing the substance on monkeys. That was four months ago, and Ginzburg, a microbiologist and director of the state-owned Gamaleya Institute in Moscow, says he is still feeling just fine. One hundred institute employees also agreed to be vaccinated. And all are still healthy.Ginzburg is working on what is called a vector vaccine, which involves introducing genetic material from the SARS-CoV-2 virus into a harmless carrier virus in order to trigger the human immune system to produce antibodies. The...WW…